Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Do you know, that buy dildos is easy and safety?
Popular Articles

Public Backs New Plans To Protect Children From Tobacco
New research shows that 70 per cent of adults in the UK back proposals to protect children from tobacco by putting it out of sight in shops and 76 per cent support abolishing cigarette vending machines according to Cancer Research UK today (Wednesday) - on the second anniversary of the smoking ban in England.
drugs without prescription
Promising Antimicrobial Attacks Virus, Stimulates Immune System
A promising antimicrobial agent already known to kill bacteria can also kill viruses and stimulate the innate immune system, according to researchers at National Jewish Health. In a paper appearing online June 4 in the Journal of Investigative Dermatology, Michael Howell, PhD, Assistant Professor of Pediatrics, and his colleagues demonstrated that the synthetic compound CSA-13 can kill vaccinia virus in cell cultures and in mice. Additionally, they showed that CSA-13 stimulates cells to produce their own antimicrobial proteins.
News of the day
Glutamine Supplements Show Promise In Treating Stomach Ulcers
Nearly 20 years ago, it was discovered that bacteria known as Helicobacter pylori were responsible for stomach ulcers. Since then, antibiotics have become the primary therapy used to combat the H. pylori infection, which affects approximately six percent of the world population and is also a primary cause of stomach cancer. But today the bacteria is growing increasingly resistant to antibiotics.
Oncology

Ureteropelvic Junction Obstruction Secondary To Crossing Vessels-To Transpose Or Not? The Robotic Experience

UroToday.com - "Good judgment comes from experience, experience (unfortunately) comes from bad judgment." So the saying goes, but perhaps good judgment can (hopefully) come from carefully done reading of the "experiences" of others. In this excellent manuscript, the authors report on both the objective (i.e. renal scan) and subjective (i.e. analog pain scores) outcomes of 107 patients undergoing a robotic dismembered pyeloplasty for ureteropelvic junction obstruction (UPJO). Following the lead of Gill and colleagues, the authors noted that among the 45% of their patients who presented with UPJO and an associated crossing vessel, it was feasible to perform a tension free anastomosis with the standard repositioning of the pelvis anterior to the crossing vessel(s) in only one third of the cases (37.5%). In each of the patients in whom the vessels were not transposed, a standard dismembered robotic pyeloplasty was performed such that there was at least a 1 cm distance between the reconstructed ureteropelvic junction and the crossing vessel. The authors don"t mention whether they used any reconstructive measures to fix the vessels in a higher position (e.g. Hellstrom technique). The results were uniformly excellent with 100% radiographic and symptomatic rate of success. In both groups, differential function improved by 10%, T÷½ fell below 10 minutes, and mean pain scores were under 1.0 on a scale of 10. Of note, the mean follow-up was just over 1 year in both groups. The side story here is the 100% success rate in over 100 patients undergoing a dismembered pyeloplasty for UPJO. I am now seeing other groups reporting similarly high triple digit success rates for robotic pyeloplasty. One has to wonder, if the robot is providing the surgeon with better abilities than he or she would otherwise have in performing a reconstructive procedure? While further follow-up at 2 to3 years will be important, perhaps it is time to proceed with intrasurgeon comparisons for pyeloplasty, using a matched controlled retrospective analysis. The results could be most illuminating. Boylu U, Oommen M, Lee BR, Thomas R J Urol. 2009 Apr;181(4):1751-5. doi: 10.1016/j.juro.2008.11.114 Written by UroToday.com Medical Editor Ralph V. Clayman, MD UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009